Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
MedImmune Expands Gaithersburg Headquarters
MedImmune will expand its existing 361,000-sf headquarters campus in Gaithersburg, Fla., with the construction of a 250,000-sf facility. Construction of the seven-story building will begin in 2009 and reach completion in late 2011. The facility will provide pharmaceutical laboratories and offices for up to 600 employees. MedImmune is a subsidiary of AstraZeneca.
Polar Research Station Begins Second Construction Phase
The International Polar Foundation initiated the second phase of construction at the €22 million Princess Elisabeth Antarctica research station in November of 2008. The first construction phase, comprised of the exterior shell, was completed in early 2008. The 400-sm environmental research station will be officially inaugurated in February of 2009 after all interior systems have been installed and integrated. Located in Utsteinen, Antarctica, the zero-emission facility can withstand extreme temperatures and features solar panels, wind turbines, and water recycling.
Yale University Completes Biosafety Lab
Yale University’s new BSL-3 laboratory will open in early 2009. Located on the ninth floor of the School of Public Health building in New Haven, Conn., the facility will support animal and non-animal research on infectious diseases including West Nile Virus, SARS, Yellow Fever, and anthrax. The laboratory features a single-pass airflow system, waterproof ceilings, and completely sealed penetrations.
Colorado State University Constructs Research Innovation Center
Colorado State University began building the $53 million Research Innovation Center on its Foothills campus in Fort Collins in December of 2008. Slated for completion in April of 2010, the three-story, 72,000-sf center will be sited in the Judson Harper Research Complex and will house offices, laboratories, and a biotechnology business incubator.
Medicago Expands Avian Flu Vaccine Production
Medicago is initiating a $1.5 million expansion of its Quebec City manufacturing facility to support avian flu vaccine production for clinical trials. The 2,500-sf addition will include purification, storage, and cGMP vaccine manufacturing space. Construction will begin in January 2009 and reach completion by year-end 2009. Medicago’s existing building, housing 10,000-sf of BSL-2 space and 3,000-sf of cGMP manufacturing space, will begin production of an H5N1 vaccine for Phase 1 clinical trials in 2009. The new addition will house Phase 2 clinical studies.